Results 31 to 40 of about 392,831 (250)

Medical Laboratory Sciences: Spring 2023 Clinical Rotation

open access: yes, 2023
On photo: left to right - top row: Kiley Beeson, Annie HindsMiddle row (left to right): Tiffani Holman, Bailey Owings, Duong PhamBottom row (left to right): Garrett Smith, Eric TuongDigitized by University Libraries' Technical Services Institutional ...
Medical Laboratory Sciences   +1 more
core  

"Positive" Results Increase Down the Hierarchy of the Sciences [PDF]

open access: yes, 2010
The hypothesis of a Hierarchy of the Sciences with physical sciences at the top, social sciences at the bottom, and biological sciences in-between is nearly 200 years old.
Daniele Fanelli   +3 more
core   +1 more source

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen   +23 more
wiley   +1 more source

Medical Laboratory Sciences: Spring 2022 Clinical Rotation

open access: yes, 2022
On photo: left to right - top row: Lindsay Beeman, Danielle Bise, ThaoMiddle row (left to right): Bo Li, Elena Lovelace, Nubia MarinezBottom row (left to right): Leah Schaper, Noely Urbina, Kelsey YoungDigitized by University Libraries' Technical ...
Medical Laboratory Sciences   +1 more
core  

Health‐Related Quality of Life and Symptom Severity Among Patients With PIK3CA‐Related Overgrowth Spectrum: A Mixed‐Methods Study to Understand Real‐World Experience With Alpelisib Treatment

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background PIK3CA‐related overgrowth spectrum (PROS) includes several rare overgrowth disorders resulting from somatic gain‐of‐function mutations in PIK3CA. Despite treatment advances, including the recent approval of alpelisib for PROS in the United States, literature detailing the patient experience with PROS is limited.
Vamsi Bollu   +8 more
wiley   +1 more source

Clinical and Biological Features of Response in Resistant Neuroblastoma to 131I‐Metaiodobenzylguanidine Radiotherapy in the Anti‐GD2 Immunotherapy Era

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background 131I‐metaiodobenzylguanidine (131I‐MIBG) radiotherapy is a key treatment for relapsed and refractory (R/R) neuroblastoma (NB). Patients with R/R disease treated in the modern era are increasingly exposed to anti‐GD2 immunotherapy, which exerts selective pressure and may modify both tumor cell state and microenvironment.
Benjamin J. Lerman   +7 more
wiley   +1 more source

Medical Laboratory Sciences: Fall 2021 Clinical Rotation

open access: yes, 2021
On photo: left to right - top row: Ashley Caster, Aashlyn Brown, Natalie Collins, Lucero Del RealMiddle row (left to right): Nam Duong, Angel Holguin, Natalie Hughes, Abigail JantzBottom row (left to right): Sara Nulik, Dat Quach, John WyattDigitized by ...
Medical Laboratory Sciences   +1 more
core  

Hospitalization Through Families’ Eyes: Comparing Inpatient Care Quality for Children With Sickle Cell Disease and Cystic Fibrosis in Canada

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Sickle cell disease (SCD) is a chronic, inherited hemoglobinopathy that requires frequent hospitalization for disease‐related complications. Canadian data on inpatient care is limited. This study compared caregiver‐reported hospital experiences of children with SCD to those with cystic fibrosis (CF), a chronic, autosomal recessive ...
Hailey M. Zwicker   +11 more
wiley   +1 more source

UMCCTS Newsletter, August 2023

open access: yes, 2023
This is the August 2023 issue of the UMass Center for Clinical and Translational Science Newsletter containing news and events of interest.Supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through ...
UMass Center for Clinical and Translational Science
core   +1 more source

Venous Thromboembolism in Pediatric Bone Sarcoma Patients: A 10‐Year, Single‐Institution Experience Encompassing the COVID‐19 Pandemic

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Osteosarcoma (OS) and Ewing sarcoma (EWS) are the most common primary bone cancers in children, but acute thrombosis is poorly characterized in this population. Our study evaluated the rates of venous thromboembolism (VTE) and associated risk factors in pediatric patients with bone sarcomas treated over a 10‐year period encompassing
Sarah Kappa   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy